According to Axon Enterprise 's latest financial reports and stock price the company's current number of shares outstanding is 74,826,000. At the end of 2023 the company had 74,826,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 74.82 M | 4.99% |
2022 | 71.27 M | 2.83% |
2021 | 69.31 M | 8.91% |
2020 | 63.63 M | 7.18% |
2019 | 59.37 M | 1.49% |
2018 | 58.5 M | 10.56% |
2017 | 52.91 M | 1.17% |
2016 | 52.29 M | -2.55% |
2015 | 53.66 M | 1.73% |
2014 | 52.75 M | 0.8% |
2013 | 52.33 M | -0.33% |
2012 | 52.5 M | -10.68% |
2011 | 58.78 M | -5.7% |
2010 | 62.34 M | 0.65% |
2009 | 61.93 M | 0.36% |
2008 | 61.71 M | -1.96% |
2007 | 62.95 M | 1.48% |
2006 | 62.03 M | 1.05% |
2005 | 61.38 M | 5.92% |
2004 | 57.95 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
XBiotech XBIT | 30,436,638 | -59.32% | ๐บ๐ธ USA |
Sangamo Therapeutics
SGMO | 177,171,000 | 136.78% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | 38,562,800 | -48.46% | ๐บ๐ธ USA |
Exelixis EXEL | 308,482,000 | 312.27% | ๐บ๐ธ USA |